Ochijewicz Dorota, Tomaniak Mariusz, Kołtowski Lukasz, Rdzanek Adam, Pietrasik Arkadiusz, Proniewska Klaudia, Partyka Lukasz, Dijsktra Jouke, Huczek Zenon, Filipiak Krzysztof, Opolski Grzegorz, Kochman Janusz
1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Int J Cardiol. 2020 Aug 1;312:27-32. doi: 10.1016/j.ijcard.2020.04.051. Epub 2020 Apr 18.
Peri-strut low intensity areas (PLIA) visualized by optical coherence tomography (OCT) have been related to neointimal proliferation and increased incidence of target lesion revascularization in stable coronary artery disease. The aim of this study was to determine the association between PLIA by OCT and the long-term vascular healing response after bioresorbable scaffold (BRS) implantation in the setting of ST-segment elevation myocardial infarction (STEMI).
This is a single-centre, longitudinal, cohort study with a serial: baseline, 1, 2 and 5 years OCT evaluation of neointimal response (lumen area and neoatherosclerosis) after percutaneous coronary intervention (PCI) with BRS Absorb™ 1.0 implantation in patients presenting with STEMI. PLIA was analyzed in every cross section and scored: 0-no PLIA; 1-PLIA < 1 quadrant; 2-PLIA ≥ 1 and <2 quadrants; 3-PLIA ≥ 2 and <3 quadrants; 4-PLIA in ≥3 quadrants.
Of the 23 patients implanted BRS, 18 completed 2-year follow-up, whereas complete OCT data up to 5 years were available in 12 patients. Presence of PLIA was identified in 100% patients at 1 and 2 years, whereas at 5 years neither PLIA nor scaffold struts were visualized by OCT. Neoatherosclerosis was identified in 73,68% patients after 1 year and in all patients at 2 and 5 years. The mean PLIA score > 1 at 2 years was associated with greater percentage of minimum lumen area decrease after 2 years from index procedure.
The extent of PLIA by OCT at 2 years after primary PCI with BRS was associated with lumen area decrease. Neoatherosclerosis formation was detected in all patients at 2 and 5 years. PLIA assessment could serve as an additive means to predict neointimal healing pattern after next generation BRS implantation.
光学相干断层扫描(OCT)显示的支架周围低强度区域(PLIA)与稳定型冠状动脉疾病中的新生内膜增生及靶病变血运重建发生率增加有关。本研究的目的是确定在ST段抬高型心肌梗死(STEMI)背景下,OCT检测的PLIA与生物可吸收支架(BRS)植入后长期血管愈合反应之间的关联。
这是一项单中心、纵向队列研究,对STEMI患者植入BRS Absorb™ 1.0进行经皮冠状动脉介入治疗(PCI)后,进行系列的基线、1年、2年和5年的OCT评估新生内膜反应(管腔面积和新生动脉粥样硬化)。在每个横截面分析PLIA并进行评分:0-无PLIA;1-PLIA<1个象限;2-PLIA≥1且<2个象限;3-PLIA≥2且<3个象限;4-PLIA≥3个象限。
在23例植入BRS的患者中,18例完成了2年随访,而12例患者可获得长达5年的完整OCT数据。在1年和2年时,100%的患者检测到PLIA,而在5年时,OCT未显示PLIA和支架小梁。1年后,73.68%的患者检测到新生动脉粥样硬化,2年和5年时所有患者均检测到。2年时平均PLIA评分>1与首次手术后2年最小管腔面积减少的百分比更大有关。
BRS初次PCI术后2年时,OCT检测的PLIA范围与管腔面积减少有关。在2年和5年时,所有患者均检测到新生动脉粥样硬化形成。PLIA评估可作为预测下一代BRS植入后新生内膜愈合模式的补充手段。